BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a BTG International group company (BTG plc (LSE: BTG)), today announces the start of patient enrollment for the ACCelerated ThrombolySiS for Post-Thrombotic Syndrome using the EKOS® System (ACCESS PTS) Study.
Help employers find you! Check out all the jobs and post your resume.
